Researchers at George Washington University hope to develop a vaccine to prevent an infection that is afflicting more than half a billion people around the world. “This is one of the neglected tropical diseases that has the highest impact on health globally,” said David Diemert, an associate professor of microbiology, immunology and tropical medicine, who has been working with colleagues for more than a decade hoping to eradicate the effects of the hookworm parasite. Take a look at the article for more information on why you should participate in the study.
GW seeks volunteers to let parasitic worms burrow into their skin. Any takers?
Latest News
The GW VRU is proud to announce our newest publication to describe the development of a new Na-GST-1/Alhydrogel hookworm vaccine. This study showed promising results and can be read at the link below:
You are invited to attend the first featured presentation in the "State-of-the-Art Topics in Vaccinology" Seminar Series on Tuesday January 28, 2025 at 2 pm. by Dr. Nadine Rouphael, Executive Director of the Hope Clinic at the Emory Vaccine Center.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV